Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Convenience, the bane of our existence, and other barriers to donating.

Schreiber GB, Schlumpf KS, Glynn SA, Wright DJ, Tu Y, King MR, Higgins MJ, Kessler D, Gilcher R, Nass CC, Guiltinan AM; National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study.

Transfusion. 2006 Apr;46(4):545-53.

PMID:
16584430
2.

Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication.

Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E.

Virology. 2006 Feb 5;345(1):13-21. Epub 2005 Oct 26.

3.

The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.

Kleinman SH, Glynn SA, Higgins MJ, Triulzi DJ, Smith JW, Nass CC, Garratty G, Murphy EL, LeParc GF, Schreiber GB, King MR, Chamberland ME, Nemo GJ.

Transfusion. 2005 Jul;45(7):1073-83.

PMID:
15987350
4.

A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II.

Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL; HTLV Outcomes Study Investigators.

J Infect Dis. 2005 May 1;191(9):1490-7. Epub 2005 Mar 31.

PMID:
15809908
5.

The impact of male-to-male sexual experience on risk profiles of blood donors.

Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2005 Mar;45(3):404-13.

PMID:
15752159
6.

Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.

Wang B, Higgins MJ, Kleinman S, Schreiber GB, Murphy EL, Glynn SA, Wright DJ, Nass CC, Chang D, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2004 Aug;44(8):1243-51.

PMID:
15265131
7.

Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D; HTLV Outcomes Study Investigators.

J Infect Dis. 2004 Aug 1;190(3):504-10. Epub 2004 Jul 6.

PMID:
15243924
8.

Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study.

Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL; HOST Investigators.

Retrovirology. 2004 Mar 24;1:4.

9.

Mammalian brain consumption by blood donors in the United States: brains today, deferred tomorrow?

Schreiber GB, Sanchez AM, Garratty G, Nass CC, Tu Y, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2004 May;44(5):667-74.

PMID:
15104646
10.

Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.

Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB.

Emerg Infect Dis. 2004 Jan;10(1):109-16.

11.

Do blood donors read and understand screening educational materials?

Rugege-Hakiza SE, Glynn SA, Hutching ST, Bethel J, Nass CC, McEntire RL, Hirschler NV, Campbell JG, Ladavac A, Schreiber GB; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Aug;43(8):1075-83.

PMID:
12869113
12.

Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site.

Wang B, Schreiber GB, Glynn SA, Nass CC, Smith JW, Higgins MJ, Hutching ST, Wright DJ, McEntire RL, Murphy EL; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Jun;43(6):705-12.

PMID:
12757520
13.

Attitudes toward blood donation incentives in the United States: implications for donor recruitment.

Glynn SA, Williams AE, Nass CC, Bethel J, Kessler D, Scott EP, Fridey J, Kleinman SH, Schreiber GB; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Jan;43(1):7-16.

PMID:
12519425
14.

Knowledge of HIV/AIDS transmission and screening in United States blood donors.

Sharma UK, Schreiber GB, Glynn SA, Nass CC, Higgins MJ, Tu Y, Bethel J, Williams AE; Retrovirus Epidemiology Donor Study.

Transfusion. 2001 Nov;41(11):1341-50.

PMID:
11724976
15.

Repeat whole-blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs.

Glynn SA, Smith JW, Schreiber GB, Kleinman SH, Nass CC, Bethel J, Biswas B, Thomson RA, Williams AE; Retrovirus Epidemiology Donor Study.

Transfusion. 2001 Jun;41(6):736-43.

PMID:
11399812
16.

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE.

JAMA. 2000 Jul 12;284(2):229-35.

PMID:
10889598
17.

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ.

Hepatology. 2000 Mar;31(3):756-62.

PMID:
10706569
18.

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.

Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G.

J Infect Dis. 1999 Dec;180(6):1777-83.

PMID:
10558931
19.

Analysis of donor return behavior. Retrovirus Epidemiology Donor Study.

Ownby HE, Kong F, Watanabe K, Tu Y, Nass CC.

Transfusion. 1999 Oct;39(10):1128-35.

PMID:
10532608
20.

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.

Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ.

Arch Intern Med. 1999 Jul 12;159(13):1485-91.

PMID:
10399901
21.

Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study.

Guiltinan AM, Murphy EL, Horton JA, Nass CC, McEntire RL, Watanabe K.

Transfusion. 1998 Nov-Dec;38(11-12):1056-62.

PMID:
9838938
22.

Retention of "safe" blood donors. The Retrovirus Epidemiology Donor Study.

Thomson RA, Bethel J, Lo AY, Ownby HE, Nass CC, Williams AE.

Transfusion. 1998 Apr;38(4):359-67.

PMID:
9595018
23.
24.

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ.

J Infect Dis. 1997 Dec;176(6):1468-75.

PMID:
9395356
25.

Donor attitudes about exporting and importing blood.

Bowman RJ, Clay ME, Therkelsen DJ, Maynard B, Nass CC, Popovsky MA, Ryan TJ, Shafer AW, Riedesel P.

Transfusion. 1997 Sep;37(9):913-20.

PMID:
9308637
26.

Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.

Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):263-71.

PMID:
9117460
27.

Blood donor testing for HIV-I/II and HTLV-I/II.

Ness PM, Nass CC.

Arch Pathol Lab Med. 1994 Apr;118(4):337-41. Review.

PMID:
7909428
28.

Changes in intention to donate blood under a hypothetical condition of reduced confidentiality.

Banks HD, Williams AE, Nass CC, Gimble J.

Transfusion. 1993 Aug;33(8):671-4.

PMID:
8342235
29.

Parental occupation and childhood astrocytoma: results of a case-control study.

Kuijten RR, Bunin GR, Nass CC, Meadows AT.

Cancer Res. 1992 Feb 15;52(4):782-6.

30.
31.

Gestational and familial risk factors for childhood astrocytoma: results of a case-control study.

Kuijten RR, Bunin GR, Nass CC, Meadows AT.

Cancer Res. 1990 May 1;50(9):2608-12.

32.

Parental occupation and Wilms' tumor: results of a case-control study.

Bunin GR, Nass CC, Kramer S, Meadows AT.

Cancer Res. 1989 Feb 1;49(3):725-9.

Supplemental Content

Support Center